Eli Lilly (LLY) 2023 Valuation Model and Risk Framework

Eli Lilly (LLY) valuation model includes a sum-of-the-parts by drug (including Mounjaro blockbuster GLP-1 drug), historical financials, projections, and valuation. Assumptions can easily be adjusted by user. 
 
Free to Silver and Gold subscribers (see Plans & Pricing): https://www.specialsitsresearch.com/plans-pricing